Endonovo Therapeutics, Inc. (ENDV)
0.0000
0.00 (0.00%)
USD |
OTCM |
Oct 09, 16:00
Endonovo Therapeutics Enterprise Value : 7.104M for Oct. 9, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 09, 2026 | 7.104M |
| October 08, 2026 | 7.104M |
| October 07, 2026 | 7.104M |
| October 06, 2026 | 7.104M |
| October 05, 2026 | 7.104M |
| October 02, 2026 | 7.104M |
| October 01, 2026 | 7.104M |
| September 30, 2026 | 7.194M |
| September 29, 2026 | 7.015M |
| September 28, 2026 | 7.015M |
| September 25, 2026 | 7.015M |
| September 24, 2026 | 7.015M |
| September 23, 2026 | 7.015M |
| September 22, 2026 | 7.104M |
| September 21, 2026 | 7.194M |
| September 18, 2026 | 7.015M |
| September 17, 2026 | 7.015M |
| September 16, 2026 | 7.194M |
| September 15, 2026 | 7.194M |
| September 14, 2026 | 7.194M |
| September 11, 2026 | 7.194M |
| September 10, 2026 | 7.194M |
| September 09, 2026 | 7.194M |
| September 08, 2026 | 7.194M |
| September 04, 2026 | 7.194M |
| Date | Value |
|---|---|
| September 03, 2026 | 7.194M |
| September 02, 2026 | 7.194M |
| September 01, 2026 | 7.194M |
| August 31, 2026 | 7.194M |
| August 28, 2026 | 7.104M |
| August 27, 2026 | 7.194M |
| August 26, 2026 | 7.194M |
| August 25, 2026 | 7.194M |
| August 24, 2026 | 7.194M |
| August 21, 2026 | 7.194M |
| August 20, 2026 | 7.194M |
| August 19, 2026 | 7.194M |
| August 18, 2026 | 7.194M |
| August 17, 2026 | 7.194M |
| August 14, 2026 | 7.194M |
| August 13, 2026 | 7.194M |
| August 12, 2026 | 7.194M |
| August 11, 2026 | 7.194M |
| August 10, 2026 | 7.194M |
| August 07, 2026 | 7.104M |
| August 06, 2026 | 7.015M |
| August 05, 2026 | 7.194M |
| August 04, 2026 | 7.194M |
| August 03, 2026 | 7.194M |
| July 31, 2026 | 7.015M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Anika Therapeutics, Inc. | 248.88M |
| Accuray, Inc. | 173.91M |
| Micron Solutions, Inc. | -- |
| Perspective Therapeutics, Inc. | 70.56M |
| Orthofix Medical, Inc. | 530.99M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.5884M |
| Total Expenses (Quarterly) | 0.5884M |
| EPS Diluted (Quarterly) | -0.0003 |
| Earnings Yield | -2.40K% |
| Normalized Earnings Yield | -2400.00 |